RSC Advances
Paper
2,6-Dimethylpyridinium trinitromethanide {[2,6-DMPyH]-
2-(4-Chlorophenyl)-4,5-diphenyl-1-p-tolyl-1H-imidazole (Table 4,
C(NO2)3}. M.p: 137–139 ꢁC; yield: 98% (0.759 g); spectral data: IR entry 4). White solid; M.p: 224–226 ꢁC; yield: (method A: 96%,
(KBr): n 3437, 3054, 1634, 1384, cmꢀ1 1H NMR (400 MHz, method B: 95%); IR (KBr): n 1624, 1580, 1565, 1504 cmꢀ1; 1H NMR
;
DMSO-d6): d 2.69 (s, 6H, –CH3), 7.74 (d, 2H, J ¼ 8.0 Hz, –CH); (400 MHz, CDCl3): d 2.40 (s, 3H, –CH3), 7.17 (t, 3H, J ¼ 8.4 Hz, ArH),
8.37 (t, 1H, J ¼ 7.8 Hz, –CH), 9.55 (brs, 1H, –NH); 13C NMR (100 7.24 (t, 3H, J ¼ 8.0 Hz, ArH), 7.48 (d, 6H, J ¼ 8.8 Hz, ArH), 7.87 (d,
MHz, DMSO-d6): d 19.7, 70.2, 125.0, 146.0, 153.5; MS: m/z ¼ 258 6H, J ¼ 8.4 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 21.0, 119.7,
[M]+, 259 [M + H]+.
123.3, 125.5, 125.9, 126.3, 127.7, 128.1, 128.6, 128.9, 129.5, 138.5,
142.5, 144.9, 149.9.
1,2-Bis(4-chlorophenyl)-4,5-diphenyl-1H-imidazole (Table 4,
entry 5). Yellow solid; M.p: 209–211 ꢁC; yield: (method A: 95%,
General procedure for the synthesis of 1,2,4,5-tetrasubstituted
imidazole derivatives
1
method B: 93%); IR (KBr): n 1625, 1565, 1489, 1084 cmꢀ1; H
To a mixture of benzil/benzoin (1 mmol), aromatic aldehydes (1
mmol), amine derivatives (1 mmol) and ammonium acetate (1
mmol) in a test tube, 2,6-dimethylpyridinium trinitromethanide
was added as a novel nanostructured molten salt catalyst (0.5
mol%), and the subsequent mixture was stirred magnetically
under solvent-free conditions at room temperature. Aer the
completion of the reaction, as monitored by TLC with n-hexane–
ethyl acetate (5 : 2), ethyl acetate (10 mL) was added to the
reaction mixture, stirred and reuxed for 3 min, washed with
water (10 mL) and decanted to separate the catalyst from the
other materials (the reaction mixture was soluble in hot ethyl
acetate, while the nanostructured molten salt catalyst was
soluble in water). The aqueous layer was decanted and the
catalyst was separated aer removing the water. The remaining
catalyst was used for alternative reactions. The organic layer was
evaporated and the crude product was puried by recrystalli-
zation from ethanol–water (10 : 1). In this study, the nano-
structured molten salt catalyst was recycled and reused ve
times without signicant loss of its catalytic activity.
NMR (400 MHz, CDCl3): d 7.18 (d, 6H, J ¼ 8.8 Hz, ArH), 7.39 (t,
3H, J ¼ 8.8 Hz, ArH), 7.49 (t, 3H, J ¼ 8.4 Hz, ArH), 7.87 (d, 6H, J ¼
8.4 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 111.5, 124.7, 124.8,
126.2, 126.3, 128.5, 128.6, 129.1, 129.2, 138.4, 138.5, 142.3,
142.7, 145.8.
1-(4-Bromophenyl)-2-(4-chlorophenyl)-4,5-diphenyl-1H-imid-
azole (Table 4, entry 6). White solid; M.p: 217–219 ꢁC; yield:
(method A: 95%, method B: 94%); IR (KBr): n 1622, 1567, 1488,
1089 cmꢀ1; 1H NMR (400 MHz, CDCl3): d 7.12 (d, 6H, J ¼ 5.8 Hz,
ArH), 7.49 (t, 3H, J ¼ 5.4 Hz, ArH), 7.54 (t, 3H, J ¼ 5.8 Hz, ArH),
7.86 (d, 6H, J ¼ 5.4 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 104.0,
111.7, 112.2, 115.5, 119.6, 122.6, 129.2, 130.0, 132.3, 134.4, 137.7,
150.6, 159.2, 177.2; MS: m/z ¼ 484 [M]+.
1-(4-Chlorophenyl)-2-(2,4-dichlorophenyl)-4,5-diphenyl-1H-
imidazole (Table 4, entry 7). White solid; M.p: 246–248 ꢁC;
yield: (method A: 92%, method B: 91%); IR (KBr): n 1614, 1576,
1
1486, 1384, 1091 cmꢀ1; H NMR (400 MHz, CDCl3): d 7.37 (t,
3H, J ¼ 5.8 Hz, ArH), 7.50 (t, 3H, J ¼ 5.8 Hz, ArH), 7.59 (d, 6H, J
¼ 5.6 Hz, ArH), 7.80 (s, 1H, ArH), 8.16 (d, 4H, J ¼ 8.4 Hz, ArH);
13C NMR (100 MHz, CDCl3): d 110.0, 112.9, 117.1, 117.4, 122.5,
123.1, 124.6, 125.5, 129.4, 133.5, 134.1, 142.7, 152.5, 155.5,
158.7, 158.9; MS: m/z ¼ 474 [M]+.
Spectral data analysis for compounds
2-(4-Nitrophenyl)-4,5-diphenyl-1-p-tolyl-1H-imidazole (Table 4,
1-(4-Bromophenyl)-2-(2,4-dichlorophenyl)-4,5-diphenyl-1H-
imidazole (Table 4, entry 8). White solid; M.p: 251–253 ꢁC;
yield: (method A: 93%, method B: 92%); IR (KBr): n 1612, 1585,
ꢁ
entry 1). Yellow solid; M.p: 218–220 C; yield: (method A: 98%,
method B: 96%); IR (KBr): n 1598, 1505, 1338 cmꢀ1; 1H NMR (400
MHz, CDCl3): d 2.42 (s, 3H, –CH3), 7.23 (t, 3H, J ¼ 8.4 Hz, ArH),
7.28 (t, 3H, J ¼ 6.4 Hz, ArH), 8.10 (d, 6H, J ¼ 8.8 Hz, ArH), 8.36 (d,
6H, J ¼ 8.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 21.1, 112.1,
112.7, 112.8, 112.9, 113.4, 128.2, 128.4, 136.3, 136.5, 145.0, 149.1,
149.2, 151.2, 151.3.
1
1482, 1365, 1096 cmꢀ1; H NMR (400 MHz, CDCl3): d 7.30 (t,
3H, J ¼ 5.8 Hz, ArH), 7.60 (d, 6H, J ¼ 5.4 Hz, ArH), 7.64 (t, 3H, J
¼ 5.8 Hz, ArH), 7.80 (s, 1H, ArH), 8.16 (d, 4H, J ¼ 8.4 Hz, ArH);
13C NMR (100 MHz, CDCl3): d 123.2, 123.4, 123.7, 124.4, 124.6,
125.5, 127.6, 127.7, 128.9, 129.5, 132.7, 133.2, 134.3, 136.4,
143.2, 152.6; MS: m/z ¼ 518 [M]+.
1-(4-Chlorophenyl)-2-(4-nitrophenyl)-4,5-diphenyl-ꢁ1H-imid-
azole (Table 4, entry 2). Yellow solid; M.p: 218–220 C; yield:
(method A: 97%, method B: 95%); IR (KBr): n 1624, 1597, 1515,
1343 cmꢀ1; 1H NMR (400 MHz, CDCl3): d 7.25 (t, 3H, J ¼ 7.2 Hz,
ArH), 7.43 (t, 3H, J ¼ 8.8 Hz, ArH), 8.10 (d, 6H, J ¼ 8.8 Hz, ArH),
8.36 (d, 6H, J ¼ 8.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): d
112.0, 112.6, 112.7, 112.9, 113.4, 128.3, 128.4, 136.3, 136.7,
144.6, 149.0, 149.2, 151.2, 151.3; MS: m/z ¼ 451 [M]+.
1-(4-Chlorophenyl)-4,5-diphenyl-2-p-tolyl-1H-imidazole (Table 4,
entry 9). Yellow solid; M.p: 221–223 ꢁC; yield: (method A: 92%,
method B: 91%); IR (KBr): n 1623, 1598, 1516, 1338, 1106 cmꢀ1; 1H
NMR (400 MHz, CDCl3): d 2.42 (s, 3H, –CH3), 7.23 (t, 3H, J ¼ 8.4 Hz,
ArH), 7.27 (t, 3H, J ¼ 8.4 Hz, ArH), 8.11 (d, 6H, J ¼ 8.8 Hz, ArH), 8.36
(d, 6H, J ¼ 8.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 21.1, 113.4,
114.0, 115.0, 118.0, 118.1, 134.7, 137.0, 151.8, 152.6, 152.8, 152.9,
153.1, 160.1, 164.6.
1-(4-Bromophenyl)-2-(4-nitrophenyl)-4,5-diphenyl-ꢁ1H-imid-
azole (Table 4, entry 3). Yellow solid; M.p: 262–264 C; yield:
(method A: 98%, method B: 96%); IR (KBr): n 1624, 1596, 1513,
1340 cmꢀ1; 1H NMR (400 MHz, CDCl3): d 7.18 (t, 3H, J ¼ 5.8 Hz,
ArH), 7.58 (t, 3H, J ¼ 5.6 Hz, ArH), 8.11 (d, 6H, J ¼ 8.8 Hz, ArH),
8.36 (d, 6H, J ¼ 8.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): d
124.8, 124.9, 126.3, 128.1, 128.2, 128.5, 128.6, 129.1, 138.5,
142.2, 145.6, 152.1, 152.6, 167.6; MS: m/z ¼ 495 [M]+.
1-(4-Bromophenyl)-4,5-diphenyl-2-p-tolyl-1H-imidazole (Table 4,
ꢁ
entry 10). White solid; M.p: 228–230 C; yield: (method A: 93%,
method B: 92%); IR (KBr): n 1622, 1605, 1474, 1165 cmꢀ1; 1H NMR
(400 MHz, CDCl3): d 2.45 (s, 3H, –CH3), 7.11 (t, 3H, J ¼ 8.8 Hz, ArH),
7.32 (d, 6H, J ¼ 8.0 Hz, ArH), 7.53 (t, 3H, J ¼ 8.4 Hz, ArH), 7.81 (d,
6H, J ¼ 8.0 Hz, ArH); 13C NMR (100 MHz, CDCl3): d 21.7, 127.5,
32938 | RSC Adv., 2015, 5, 32933–32940
This journal is © The Royal Society of Chemistry 2015